This guideline updates “ Guidelines for the treatment of hyperkalemia in adults ” the recommendation to use a customized kit to treat hyperkalemia. The reported incidence of hyperkalemia in hospitalized patients is between 1 and 10%. The vast majority of cases are related to patients prescribed angiotensin converting enzyme inhibitors (ACE) or angiotensin II receptor blockers (ARBs) in conjunction with spironolactone with pre-existing or new renal failure.
Most other cases are related to potassium supplementation and prescription of diuretics/medicines with potassium-sparing properties. Etiology of hyperkalemia Renal Causes Acute or chronic renal failure Hyperkalaemic renal tubular acidosis (type IV) Mineralocorticoid deficiency (hypoaldosteronism states) Medicines that interfere with potassium excretion (amiloride, spironolactone) Medicines that interfere with the renin-angiotensin…
